InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Missling Christopher U, 董事长兼首席执行官. Director active across 2 companies, notably ANAVEX LIFE SCIENCES CORP.. In total, 5 filings have been published. Activity tracked since 29 June 2021. The latest transaction was disclosed on 11 September 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Missling Christopher U
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
187,500 股@ US$5.04100.0% 占其流量Common StockSEC:0001731122-25-001246:0
500,000 股@ US$0.9241.6% 占其流量Common StockSEC:0001731122-25-000452:0
73,380 股@ US$1.328.8% 占其流量Common StockSEC:0001731122-24-000552:0
268,000 股@ US$1.6038.5% 占其流量Common StockSEC:0001731122-23-001246:0
51,620 股@ US$1.325.9% 占其流量Common StockSEC:0001731122-21-001127:0
5 条申报中的 5 条
About Missling Christopher U
Missling Christopher U is the Chief Executive Officer of Anavex Life Sciences Corp. In this role, he is responsible for the strategic direction and operations of the company. His experience in the biopharmaceutical sector enables him to lead innovative initiatives and foster Anavex's growth. He plays a key role in developing new therapies for patients.
